These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 18296678

  • 1. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S, LIPID Study Investigators.
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [Abstract] [Full Text] [Related]

  • 2. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW.
    Circulation; 2005 Jul 05; 112(1):110-6. PubMed ID: 15983245
    [Abstract] [Full Text] [Related]

  • 3. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 05; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 05; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

  • 5. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.
    J Hypertens; 2006 Aug 05; 24(8):1531-9. PubMed ID: 16877955
    [Abstract] [Full Text] [Related]

  • 6. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D, Koenig W, Brenner H.
    Arch Intern Med; 2006 Aug 05; 166(22):2455-60. PubMed ID: 17159010
    [Abstract] [Full Text] [Related]

  • 7. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
    Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Münzel T, Cambien F, Tiret L, Blankenberg S, AtheroGene Investigators.
    Eur Heart J; 2005 Feb 05; 26(3):241-9. PubMed ID: 15618051
    [Abstract] [Full Text] [Related]

  • 8. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    Int J Cardiol; 2009 Apr 03; 133(2):173-8. PubMed ID: 18281115
    [Abstract] [Full Text] [Related]

  • 9. The value of NT-proBNP in early risk stratification of acute coronary syndromes.
    Almeida R, Mariano L, Gavina C, Pinho T, Vasconcelos M, Ferreira A, Maciel MJ, Gonçalves FR.
    Rev Port Cardiol; 2006 Jan 03; 25(1):71-5. PubMed ID: 16623357
    [Abstract] [Full Text] [Related]

  • 10. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
    Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW.
    Arch Neurol; 2006 Jan 03; 63(1):60-5. PubMed ID: 16286536
    [Abstract] [Full Text] [Related]

  • 11. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B, Lindbäck J, Jernberg T, Johnston N, Stridsberg M, Venge P, Wallentin L.
    J Am Coll Cardiol; 2005 Feb 15; 45(4):533-41. PubMed ID: 15708700
    [Abstract] [Full Text] [Related]

  • 12. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.
    N Engl J Med; 2005 Feb 17; 352(7):666-75. PubMed ID: 15716560
    [Abstract] [Full Text] [Related]

  • 13. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.
    Eur Heart J; 2009 May 17; 30(9):1057-65. PubMed ID: 19168526
    [Abstract] [Full Text] [Related]

  • 14. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.
    Anesth Analg; 2009 Nov 17; 109(5):1403-8. PubMed ID: 19843778
    [Abstract] [Full Text] [Related]

  • 15. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S, HOPE Study Investigators.
    Circulation; 2006 Jul 18; 114(3):201-8. PubMed ID: 16831981
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
    Berg T, Zdunek D, Stalke J, Dupke S, Baumgarten A, Carganico A, Hess G.
    Eur J Med Res; 2007 Apr 26; 12(4):152-60. PubMed ID: 17509959
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.
    J Hypertens; 2008 Jan 15; 26(1):26-34. PubMed ID: 18090537
    [Abstract] [Full Text] [Related]

  • 19. Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease.
    Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW.
    J Hypertens; 2007 Mar 15; 25(3):699-705. PubMed ID: 17278987
    [Abstract] [Full Text] [Related]

  • 20. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R, Iordanova N, Jarai R, Raffetseder A, Woloszczuk W, Gyöngyösi M, Geyer G, Wojta J, Huber K.
    Eur Heart J; 2005 Feb 15; 26(3):250-6. PubMed ID: 15618049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.